These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2378830)

  • 41. Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
    Jenkins PJ; Jain A; Jones SL; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):447-51. PubMed ID: 8959084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Short-term effect of delayed-action injectable bromocriptine in macroprolactinoma. French multicenter study].
    Brue T; James-Deidier A; Louvet JP; Dewailly D; Roger P; Schlienger JL; Schaison G; Hartemann P; Jaquet P
    Ann Endocrinol (Paris); 1991; 52(4):273-82. PubMed ID: 1818531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbohydrate tolerance in the puerperium during suppression of lactation with bromocriptine and oestrogens.
    Peters FD; Roemer VM
    Br J Obstet Gynaecol; 1977 Jul; 84(7):531-3. PubMed ID: 911711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].
    Walker S
    Br J Clin Pharmacol; 1975 Aug; 2(4):368P-369P. PubMed ID: 788734
    [No Abstract]   [Full Text] [Related]  

  • 45. [Inhibition of puerperal lactation using bromocryptin].
    Gibelli B
    Riv Ital Ginecol; 1977; 58(4):347-53. PubMed ID: 756602
    [No Abstract]   [Full Text] [Related]  

  • 46. Suppression of puerperal lactation by metergoline.
    Crosignani PG; Lombroso GC; Caccamo A; Reschini E; Peracchi M
    Obstet Gynecol; 1978 Jan; 51(1):113-5. PubMed ID: 619329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a new long-acting form of bromocriptine on tumorous hyperprolactinemia.
    Ciccarelli E; Ghigo E; Mazza E; Andreis M; Massara F; Lancranjan I; Camanni F
    J Endocrinol Invest; 1987 Apr; 10(2):179-82. PubMed ID: 3584856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of dihydroergocryptine on serum prolactin levels and milk secretion in puerperal women.
    Nappi C; Colace G; Di Carlo C; Affinito P; Ruotolo C; Montemagno R; Farace MJ; Mailland F; Di Renzo GF
    Gynecol Endocrinol; 1993 Jun; 7(2):129-33. PubMed ID: 8213227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum hormone changes in parturients given steroid preparations to suppress lactation.
    Lev-Gur M; Rodriguez LJ; Smith KD; Steinberger E
    Int J Fertil; 1990; 35(2):95-9. PubMed ID: 1970984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Latency and duration of the effects of bromocriptine and prolactin on milk secretion in lactating rabbits.
    Mena F; Martínez-Escalera G; Aguayo D; Clapp C; Grosvenor CE
    J Endocrinol; 1982 Sep; 94(3):389-95. PubMed ID: 7119648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation.
    Walker S; Groom G; Davis RH; Hibbard BM; Griffiths K
    Lancet; 1975 Nov; 2(7940):842-4. PubMed ID: 53330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The effect of treatment with depot-bromocriptine (CB 154-MK) on the hormone balance of the female dog].
    Arbeiter K; Dobretsberger M; Breitenfellner J; Laber G
    Dtsch Tierarztl Wochenschr; 1988 Oct; 95(9):356-60. PubMed ID: 3053108
    [No Abstract]   [Full Text] [Related]  

  • 54. Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patients.
    Pagani MD; Tengattini F; Montini M; Pagani G; Pedroncelli A; Gianola D; Gherardi F; Mazzocchi N; Cortesi L; Lancranjan I
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):369-74. PubMed ID: 1424170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The treatment of puerperal lactation with bromocriptine.
    Cooke I; Foley M; Lenton E; Preston E; Millar D; Jenkins A; Obiekwe B; McNeilly A; Parsons J; Kennedy G
    Postgrad Med J; 1976; 52suppl 1():75-80. PubMed ID: 959129
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation.
    Yuen BH; Pendleton HJ; Blair S
    Can Med Assoc J; 1977 Oct; 117(8):919-21. PubMed ID: 334356
    [No Abstract]   [Full Text] [Related]  

  • 57. [Serum prolactin levels during inhibition of lactation with 2-brom-alpha-ergocryptin (CB 154) (author's transl)].
    Gerstner G; Mick R; Spona J
    Wien Klin Wochenschr; 1977 Oct; 89(19):664-7. PubMed ID: 910447
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of lactation and season on plasma prolactin concentrations and response to bromocriptine during lactation in the Bennett's wallaby (Macropus rufogriseus rufogriseus).
    Curlewis JD; White AS; Loudon AS; McNeilly AS
    J Endocrinol; 1986 Jul; 110(1):59-66. PubMed ID: 3755462
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaginal bromocriptine in hyperprolactinemic patients and puerperal women.
    Jasonni VM; Raffelli R; de March A; Frank G; Flamigni C
    Acta Obstet Gynecol Scand; 1991; 70(6):493-5. PubMed ID: 1763616
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.
    Brue T; Lancranjan I; Louvet JP; Dewailly D; Roger P; Jaquet P
    Fertil Steril; 1992 Jan; 57(1):74-80. PubMed ID: 1730334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.